A detailed history of Royce & Associates LP transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 972,853 shares of MDXG stock, worth $9.03 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
972,853
Previous 924,314 5.25%
Holding current value
$9.03 Million
Previous $6.41 Million 10.24%
% of portfolio
0.05%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$5.65 - $7.76 $274,245 - $376,662
48,539 Added 5.25%
972,853 $5.75 Million
Q2 2024

Aug 13, 2024

BUY
$6.16 - $8.08 $170,619 - $223,799
27,698 Added 3.09%
924,314 $6.41 Million
Q1 2024

May 13, 2024

BUY
$7.61 - $8.63 $259,668 - $294,472
34,122 Added 3.96%
896,616 $6.9 Million
Q4 2023

Feb 12, 2024

SELL
$5.7 - $9.14 $31,350 - $50,270
-5,500 Reduced 0.63%
862,494 $7.56 Million
Q3 2023

Nov 09, 2023

SELL
$6.35 - $8.16 $48,933 - $62,880
-7,706 Reduced 0.88%
867,994 $6.33 Million
Q2 2023

Aug 07, 2023

BUY
$3.14 - $6.61 $105,818 - $222,757
33,700 Added 4.0%
875,700 $5.79 Million
Q1 2023

May 04, 2023

BUY
$2.97 - $4.81 $436,590 - $707,070
147,000 Added 21.15%
842,000 $2.87 Million
Q4 2022

May 23, 2023

SELL
$2.63 - $3.45 $386,610 - $507,150
-147,000 Reduced 17.46%
695,000 $1.93 Million
Q4 2022

Feb 13, 2023

BUY
$2.63 - $3.45 $394,500 - $517,500
150,000 Added 27.52%
695,000 $1.93 Million
Q3 2022

Nov 03, 2022

BUY
$2.71 - $4.22 $1.48 Million - $2.3 Million
545,000 New
545,000 $1.56 Million
Q4 2018

Feb 11, 2019

SELL
$1.15 - $6.45 $4,986 - $27,967
-4,336 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$3.22 - $6.33 $6,552 - $12,881
2,035 Added 88.44%
4,336 $27,000
Q2 2018

Aug 09, 2018

BUY
$5.39 - $8.96 $6,629 - $11,020
1,230 Added 114.85%
2,301 $15,000
Q1 2018

May 14, 2018

BUY
$6.69 - $17.96 $7,164 - $19,235
1,071 New
1,071 $7,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.